Jeil Pharma Holdings Inc (002620.KS)
KRW 7900.0
(0.25%)
KRW 7900.0
(0.25%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1059.00 KRW | 80.46% |
| 2022 | -5416.22 KRW | -546.03% |
| 2021 | -838.38 KRW | -212.59% |
| 2020 | 744.64 KRW | 111.93% |
| 2019 | -6244.10 KRW | -558.26% |
| 2018 | 1362.57 KRW | -99.02% |
| 2017 | 139.11 Thousand KRW | 6466.03% |
| 2016 | 2118.74 KRW | -18.42% |
| 2015 | 2597.16 KRW | 372.05% |
| 2014 | 550.19 KRW | 335.14% |
| 2013 | 126.44 KRW | -95.61% |
| 2012 | 2877.38 KRW | -58.36% |
| 2011 | 6909.82 KRW | 6.03% |
| 2010 | 6516.83 KRW | -9.02% |
| 2009 | 7162.70 KRW | 59.76% |
| 2008 | 4483.52 KRW | 28.25% |
| 2007 | 3495.92 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -798.67 KRW | -27735.64% |
| 2024 Q1 | 2.89 KRW | 100.16% |
| 2023 Q3 | -16.95 KRW | -120.68% |
| 2023 Q2 | 81.97 KRW | -93.04% |
| 2023 Q4 | -1762.67 KRW | -10299.23% |
| 2023 FY | - KRW | 80.46% |
| 2023 Q1 | 1177.89 KRW | 124.06% |
| 2022 Q3 | -184.63 KRW | -579.54% |
| 2022 Q2 | -27.17 KRW | 91.3% |
| 2022 Q1 | -312.13 KRW | 35.24% |
| 2022 FY | - KRW | -546.03% |
| 2022 Q4 | -4895.06 KRW | -2551.28% |
| 2021 Q4 | -482.00 KRW | -830.3% |
| 2021 Q1 | 57.00 KRW | -67.17% |
| 2021 Q2 | 131.00 KRW | 129.82% |
| 2021 Q3 | 66.00 KRW | -49.62% |
| 2021 FY | - KRW | -212.59% |
| 2020 Q4 | 173.61 KRW | 68.55% |
| 2020 FY | - KRW | 111.93% |
| 2020 Q1 | 269.00 KRW | 104.25% |
| 2020 Q2 | 199.00 KRW | -26.02% |
| 2020 Q3 | 103.00 KRW | -48.24% |
| 2019 Q2 | 168.00 KRW | 58.49% |
| 2019 Q1 | 106.00 KRW | -80.66% |
| 2019 Q4 | -6322.22 KRW | -4714.76% |
| 2019 Q3 | 137.00 KRW | -18.45% |
| 2019 FY | - KRW | -558.26% |
| 2018 FY | - KRW | -99.02% |
| 2018 Q4 | 548.04 KRW | 20.45% |
| 2018 Q3 | 455.00 KRW | -12.33% |
| 2018 Q2 | 519.00 KRW | 42.98% |
| 2018 Q1 | 363.00 KRW | -98.54% |
| 2017 Q2 | 179.77 Thousand KRW | 67346.26% |
| 2017 FY | - KRW | 6466.03% |
| 2017 Q1 | 266.55 KRW | -93.53% |
| 2017 Q3 | -494.00 KRW | -100.27% |
| 2017 Q4 | 24.89 Thousand KRW | 5139.07% |
| 2016 Q1 | 519.43 KRW | 34.57% |
| 2016 Q3 | 1076.46 KRW | 30.71% |
| 2016 Q4 | 4118.65 KRW | 282.61% |
| 2016 Q2 | 823.57 KRW | 58.55% |
| 2016 FY | - KRW | -18.42% |
| 2015 FY | - KRW | 372.05% |
| 2015 Q4 | 386.00 KRW | -60.37% |
| 2015 Q3 | 973.94 KRW | 0.0% |
| 2015 Q2 | 973.94 KRW | 223.87% |
| 2015 Q1 | 300.72 KRW | 142.08% |
| 2014 Q2 | 895.34 KRW | 235.9% |
| 2014 Q1 | 266.55 KRW | 129.38% |
| 2014 FY | - KRW | 335.14% |
| 2014 Q4 | -714.62 KRW | -733.7% |
| 2014 Q3 | 112.77 KRW | -87.4% |
| 2013 Q3 | 184.54 KRW | 1.89% |
| 2013 Q4 | -907.20 KRW | -591.6% |
| 2013 FY | - KRW | -95.61% |
| 2013 Q1 | 642.46 KRW | 286.76% |
| 2013 Q2 | 181.12 KRW | -71.81% |
| 2012 Q4 | -344.01 KRW | -129.61% |
| 2012 FY | - KRW | -58.36% |
| 2012 Q1 | 1172.14 KRW | 22141.75% |
| 2012 Q2 | 902.17 KRW | -23.03% |
| 2012 Q3 | 1161.89 KRW | 28.79% |
| 2011 FY | - KRW | 6.03% |
| 2011 Q4 | 5.27 KRW | -99.83% |
| 2011 Q3 | 3075.59 KRW | 151.4% |
| 2011 Q2 | 1223.40 KRW | -53.26% |
| 2011 Q1 | 2617.67 KRW | 46.9% |
| 2010 Q2 | 1196.06 KRW | -20.27% |
| 2010 FY | - KRW | -9.02% |
| 2010 Q4 | 1781.97 KRW | -12.36% |
| 2010 Q3 | 2033.31 KRW | 70.0% |
| 2010 Q1 | 1500.20 KRW | 9.34% |
| 2009 Q1 | 1657.40 KRW | 90.3% |
| 2009 Q2 | 2002.55 KRW | 20.82% |
| 2009 Q3 | 2132.41 KRW | 6.48% |
| 2009 Q4 | 1372.03 KRW | -35.66% |
| 2009 FY | - KRW | 59.76% |
| 2008 Q3 | 1096.96 KRW | -36.44% |
| 2008 Q2 | 1725.75 KRW | 117.67% |
| 2008 Q1 | 792.82 KRW | -8.63% |
| 2008 Q4 | 870.93 KRW | -20.61% |
| 2008 FY | - KRW | 28.25% |
| 2007 Q1 | 610.57 KRW | 0.0% |
| 2007 Q4 | 867.67 KRW | -25.55% |
| 2007 Q3 | 1165.48 KRW | 29.68% |
| 2007 Q2 | 898.76 KRW | 47.2% |
| 2007 FY | - KRW | 0.0% |